At Immune Propulsion, our mission is to revolutionize cancer therapy through the innovative use of enzyme-cleaved antibodies. We aim to harness the body's immune system to restore and enhance the efficacy of both established anti-cancer monoclonal antibodies and natural host antitumor antibodies. Our proprietary, innovative and novel approach is designed to address the complexities of solid tumors, potentially improving patient outcomes and providing new avenues for improving the quality of life. Leveraging decades of research, we are driven by a commitment to scientific excellence, collaboration, and the relentless pursuit of knowledge in the field of immunotherapy.

Time is of the Essence

Our approach to the treatment of cancer is ready for a clinical proof of practice. The proposed approach is simple, inexpensive, and involves agents that are already approved for clinical use.